Genomic Medicine

1. Scaling AAV Manufacturing To 1000 L: Strategies For Robust Production 9/15/2026

   Learn how integrated cell line, media, and process design can support consistent AAV production at larger volumes while maintaining productivity and quality, as well as reducing scale-up risk.

2. Reducing Timelines And Development Costs Through Scale Up 9/11/2026

   See how an engineering-based approach to bioreactor scale-up delivered comparable cell growth, metabolic profiles, and product performance across cell lines and vessel sizes, helping reduce risks.

3. Scaling AAV Purification: UF/DF Technologies That Deliver 9/11/2026

   Examine a data-driven comparison of hollow-fiber and flat-sheet TFF technologies for AAV manufacturing, covering process performance, scalability, engineering considerations, and cost.

4. How Cell Therapy's Fundamentally Different Model Impacts Patients 9/1/2026

   Examine the evolution of autologous CAR T therapies, their patient-specific manufacturing workflow, key similarities and differences with biologics production, and real-world approaches.

5. Viral Safety Considerations In Process Development 9/1/2026

   Explore how upstream media filtration and downstream anion exchange chromatography can work together to manage viral risk, strengthen AAV process development, and support reliable GMP production.

6. Genomic Medicine At An Inflection Point 9/1/2026

   In vivo therapies and streamlined ex vivo manufacturing are redefining genomic medicine. Understand the tradeoffs, priorities, and technical challenges influencing how future treatments are designed.